A clinical stage biopharmaceutical company that specializes in developing allogeneic, off-the-shelf, invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated diseases.
New York, NY, United States~31 employeesFounded Jan 2017Website